FDA Asked How to Unblind Blood Cancer Trials

Drug Industry Daily
A A
Drug companies and a contract research organization are urging the FDA to sharpen its recommendations on how to reveal to blood cancer patients whether they’re taking placebos or the real thing in clinical trials.

To View This Article:

Login

Subscribe To Drug Industry Daily